FENNEC PHARMACEUTICALS INC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.98 USD | -1.41% |
|
+3.66% | +10.97% |
| 05-15 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
| 05-14 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 115B | ||||||
| 106B | ||||||
| 24.69B | - | |||||
| 21.97B | - | |||||
| 19.27B |
